Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan

BONE MARROW TRANSPLANTATION

卷 40, 期 9, 页码 913-914

NATURE PUBLISHING GROUP

-

Biophysics Oncology Hematology Immunology Transplantation